Dr Corinne Portioli received her BSc in Biotechnology and MSc in Medical and Pharmaceutical Biotechnology from the University of Modena and Reggio Emilia, IT. She then obtained a PhD in Neuroscience at the University of Verona, IT and Doctor Europaeus due to her Visiting PhD student experience at the University of Manchester, UK. Corinne joined IIT (Cancedda and De Vivo Labs) in 2017 before moving to Baylor College of Medicine, US (Zhou Lab) to work on structural biology projects aimed at finding new cures for neurological diseases. From 2019 to 2021 she was Marie Skłodowska-Curie Individual Fellow (GF) Researcher with a project focused on elucidating the structure-function relationship of NKCC1, ion co-transporter, a promising drug target for neurodevelopmental disorders. She joined MINDED programme in July 2021 to work on the in vitro and in vivo characterization of drug delivery systems in neurodevelopmental disorders. Her research field focuses on the use of an interdisciplinary approach (cell/molecular biology, structural biology, computational chemistry and nanomedicine) to tackle the need of novel therapeutic treatments in neurological disorders.
Koray Ertan, Ph.D.
Martina Pannuzzo, Ph.D.
Elena Bellotti, Ph.D.
Shoshy Mizrahy, Ph.D.
Sayanti Brahmachari, Ph.D.
Lucilla Cardinali, Ph.D.
Wei Chien, Ph.D.
Peter Gawne, Ph.D.
Claudia Giambartolomei, Ph.D.
Ana Martins, Ph.D.
Flávia Cristina Moreira de Sousa, Ph.D.
Dr. James Strachan, Ph.D.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 754490.
The content of this webiste is the sole responsibility of the authors. The European Commission or its services cannot be held responsible for any use that may be made of the information it contains.